The DOI matches its Crossref record; 499 of the 499 references it cites were found in a registry or an index.
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–400 of 499
Navarro, A., Boveris, A., Bández, M. J., Sánchez-del-Pino, M. J., Gómez, C., Muntané, G., & Ferrer, I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.007 · Cited by 142
Francis, P. T., & Perry, E. K. (2007) · Movement Disorders · doi:10.1002/mds.21683 · Cited by 141
Tsuboi, Y., Uchikado, H., & Dickson, D. W. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70005-1 · Cited by 141
Kao, A. W., Racine, C. A., Quitania, L., Kramer, J. H., Christine, C. W., & Miller, B. L. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181b5065d · Cited by 140
Haggerty, T., Credle, J. J., Rodriguez, O. C., Wills, J., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07660.x · Cited by 140
18 F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies
Whitwell, J. L., Graff‐Radford, J., Singh, T. D., Drubach, D. A., Senjem, M. L., Spychalla, A. J., Tosakulwong, N., Lowe, V. J., & Josephs, K. A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.179903 · Cited by 139
Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
Harper, L., Bouwman, F. H., Burton, E. J., Barkhof, F., Scheltens, P., O'Brien, J. T., Fox, N. C., Ridgway, G. R., & Schott, J. M. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314978 · Cited by 137
Cognitive and behavioral disorders in Parkinson’s disease: an update. I: cognitive impairments
Papagno, C., & Trojano, L. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3154-8 · Cited by 137
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies
Colom‐Cadena, M., Pegueroles, J., Herrmann, A. G., Henstridge, C. M., Muñoz, L., Querol‐Vilaseca, M., Martín-Paniello, C. S., Luque-Cabecerans, J., Clarimón, J., Belbin, O., et al. (2017) · Brain · doi:10.1093/brain/awx275 · Cited by 136
Burton, E. J., McKeith, I. G., Burn, D. J., Firbank, M., & O'Brien, J. T. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000236596.56982.1c · Cited by 135
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance
Rothaug, M., Zunke, F., Mazzulli, J. R., Schweizer, M., Altmeppen, H. C., Lüllmann‐Rauch, R., Kallemeijn, W. W., Gaspar, P., Aerts, J. M. F. G., Glatzel, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405700111 · Cited by 134
Lehéricy, S., Vaillancourt, D. E., Seppi, K., Monchi, O., Rektorová, I., Antonini, A., McKeown, M. J., Masellis, M., Berg, D., Rowe, J. B., et al. (2017) · Movement Disorders · doi:10.1002/mds.26968 · Cited by 133
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case.
Marquié, M., Verwer, E. E., Meltzer, A. C., Kim, S. J. W., Agüero, C., Gonzalez, J., Makaretz, S. J., Siao Tick Chong, M., Ramanan, P., Amaral, A. C., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0482-0 · Cited by 128
Apolipoprotein E and Dementia in Parkinson Disease: A Meta-analysis
Huang, X., Chen, P., Kaufer, D. I., Tröster, A. I., & Poole, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.189 · Cited by 128
Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease
Sharabi, Y., & Goldstein, D. S. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.06.047 · Cited by 126
Kitao, S., Matsusue, E., Fujii, S., Miyoshi, F., Kaminou, T., Kato, S., Ito, H., & Ogawa, T. (2013) · Neuroradiology · doi:10.1007/s00234-013-1199-9 · Cited by 125
Neuroimaging characteristics of dementia with Lewy bodies
Mak, E., Su, L., Williams, G. B., & O’Brien, J. T. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt248 · Cited by 120
Compta, Y., Valente, T., Saura, J., Segura, B., Iranzo, Á., Serradell, M., Junqué, C., Tolosa, E. S., Valldeoriola, F., Muñoz, E., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7560-z · Cited by 119
Papathanasiou, N. D., Boutsiadis, A., Dickson, J. C., & Bomanji, J. B. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.09.015 · Cited by 118
Burton, E. J., McKeith, I. G., Burn, D. J., & O'Brien, J. T. (2005) · Movement Disorders · doi:10.1002/mds.20652 · Cited by 118
McKeith, I. G., Taylor, J., Thomas, A. J., Donaghy, P. C., & Kane, J. P. M. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716656083 · Cited by 118
Babiloni, C., Percio, C. D., Lizio, R., Noce, G., Cordone, S., Lopez, S., Soricelli, A., Ferri, R., Pascarelli, M. T., Nobili, F. M., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.030 · Cited by 118
A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits
Donadio, V. A., Incensi, A., Rizzo, G., Capellari, S., Pantieri, R., Maserati, M. S., Devigili, G., Eleopra, R., Defazio, G., Montini, F., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004146 · Cited by 117
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Strafella, A. P., Bohnen, N. I., Perlmutter, J. S., Eidelberg, D., Pavese, N., van Eimeren, T., Piccini, P. P., Politis, M., Thobois, S., Ceravolo, R., et al. (2017) · Movement Disorders · doi:10.1002/mds.26907 · Cited by 116
Garn, H., Coronel, C., Waser, M., Caravias, G., & Ransmayr, G. N. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1699-6 · Cited by 116
Dugger, B. N., Boeve, B. F., Murray, M. E., Parisi, J. E., Fujishiro, H., Dickson, D. W., & Ferman, T. J. (2011) · Movement Disorders · doi:10.1002/mds.24003 · Cited by 115
CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
Terrelonge, M., Marder, K. S., Weintraub, D. A., & Alcalay, R. N. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0647-x · Cited by 114
Albasanz, J. L., Dalfó, E., Ferrer, I., & Martín, M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.001 · Cited by 114
Lee, J., Park, H., Park, B., Song, S. K., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.184747 · Cited by 114
van Steenoven, I., Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C., Mollenhauer, B., Fladby, T., Kramberger, M., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160322 · Cited by 113
Meta‐analysis of 123I‐MIBG cardiac scintigraphy for the diagnosis of Lewy body–related disorders
King, A. E., Mintz, J., & Royall, D. R. (2011) · Movement Disorders · doi:10.1002/mds.23659 · Cited by 112
Lebedev, A. V., Westman, E., Simmons, A., Lebedeva, A., Siepel, F. J., Pereira, J. B., & Aarsland, D. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00045 · Cited by 112
Ikeda, M., Mori, E., Matsuo, K., Nakagawa, M., & Kosaka, K. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0083-0 · Cited by 112
Biomarkers of cognitive decline in Parkinson's disease
Lin, C., & Wu, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.010 · Cited by 111
Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies
Deramecourt, V., Bombois, S., Maurage, C., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F., & Delacourte, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000205145.54457.ea · Cited by 111
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Ruiz, C. A., van Steenoven, I., Londos, E., Blanc, F., Auestad, B., Kramberger, M. G., Zetterberg, H., Mollenhauer, B., Boada, M., & Aarsland, D. (2016) · Movement Disorders · doi:10.1002/mds.26668 · Cited by 111
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
Goldman, J. G., Goetz, C. G., Brandabur, M., Sanfilippo, M., & Stebbins, G. T. (2008) · Movement Disorders · doi:10.1002/mds.22322 · Cited by 109
Dementia with Lewy bodies and Parkinson's disease
McKeith, I. G., & Mosimann, U. P. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.12.005 · Cited by 109
Simonsen, A. H., Kuiperij, H. B., El‐Agnaf, O. M. A., Engelborghs, S., Herukka, S., Parnetti, L., Rektorová, I., Vanmechelen, E., Kapaki, E. N., Verbeek, M. M., et al. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.105 · Cited by 107
Event-related potentials and cognition in Parkinson’s disease: An integrative review
Seer, C., Lange, F., Georgiev, D., Jahanshahi, M., & Kopp, B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.003 · Cited by 107
123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders
Rascol, O., & Schelosky, L. D. (2009) · Movement Disorders · doi:10.1002/mds.22499 · Cited by 106
Almeida, O. P., Burton, E. J., McKeith, I. G., Gholkar, A. R., Burn, D. J., & O'Brien, J. T. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000070676 · Cited by 104
Swirski, M., Miners, J. S., de Silva, R., Lashley, T., Ling, H., Holton, J. L., Révész, T., & Love, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0077-y · Cited by 104
Fritz, N. E., Kegelmeyer, D. A., Kloos, A., Linder, S., Park, A., Kataki, M., Adeli, A., Agrawal, P., Scharre, D. W., & Kostyk, S. K. (2016) · Gait & Posture · doi:10.1016/j.gaitpost.2016.08.009 · Cited by 104
Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
Halliday, G. M., Song, Y. J. C., & Harding, A. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0641-6 · Cited by 103
Pizzi, S. D., Franciotti, R., Taylor, J., Thomas, A., Tartaro, A., ONOFRJ, M. C., & Bonanni, L. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu220 · Cited by 103
Neuropathologic differences by race from the National Alzheimer's Coordinating Center
Graff‐Radford, N. R., Besser, L. M., Crook, J. E., Kukull, W. A., & Dickson, D. W. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.03.004 · Cited by 103
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia
Petrou, M., Bohnen, N. I., Müller, M. L. T. M., Koeppe, R. A., Albin, R. L., & Frey, K. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182698d4a · Cited by 102
Cerebral Metabolic Dysfunction in Patients with Dementia with Lewy Bodies and Visual Hallucinations
Perneczky, R., Drzezga, A. E., Boecker, H., Förstl, H., Kurz, A., & Häussermann, P. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000132084 · Cited by 101
Ruffmann, C., Calboli, F. C. F., Bravi, I., Gveric, D. O., Curry, L. K., de Smith, A. J., Pavlou, S., Buxton, J. L., Blakemore, A. I. F., Takousis, P., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12294 · Cited by 101
Chen, B., Fan, G. G., Liu, H., & Wang, S. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.04.014 · Cited by 101
α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
Guella, I., Evans, D. M., Szu‐Tu, C., Nosova, E., Bortnick, S., SNCA Cognition Study Group, Goldman, J. G., Dalrymple‐Alford, J. C., Geurtsen, G. J., Litvan, I., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24664 · Cited by 101
Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., Boeve, B. F., Graff‐Radford, J., Rocca, W. A., & Mielke, M. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0603 · Cited by 101
In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution
Weisman, D., Cho, M., Taylor, C., Adame, A., Thal, L. J., & Hansen, L. A. (2007) · Neurology · doi:10.1212/01.wnl.0000266626.64913.0f · Cited by 100
Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease
Fujita, M., Ichise, M., Zoghbi, S. S., Liow, J., Ghose, S., Vines, D. C., Sangare, J., Lu, J., Cropley, V., Iida, H., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20688 · Cited by 100
Guerreiro, R. J., Escott‐Price, V., Darwent, L., Parkkinen, L., Ansorge, O., Hernandez, D. G., Nalls, M. A., Clark, L. N., Honig, L. S., Marder, K. S., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.028 · Cited by 99
Regional Overlap of Pathologies in Lewy Body Disorders
Colom‐Cadena, M., Grau‐Rivera, O., Planellás, L., Cerquera‐Cleves, C., Morenas‐Rodríguez, E., Helgueta, S., Muñoz, L., Kulisevsky, J., Martí, M. J., Tolosa, E. S., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx002 · Cited by 99
Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology
Skogseth, R. E., Hortobágyi, T., Soennesyn, H., Chwiszczuk, L. J., Ffytche, D. H., Rongve, A., Ballard, C. G., & Aarsland, D. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170274 · Cited by 99
Barber, R., McKeith, I., Ballard, C., & O'Brien, J. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.406 · Cited by 98
Brooks, D. J. (2009) · Movement Disorders · doi:10.1002/mds.22581 · Cited by 97
Review: The spectrum of clinical features seen with alpha synuclein pathology
Barker, R., & Williams‐Gray, C. H. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12303 · Cited by 96
Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 95
Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A
Aoki, N., Murray, M. E., Ogaki, K., Fujioka, S., Rutherford, N. J., Rademakers, R., Ross, O. A., & Dickson, D. W. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1358-z · Cited by 95
Mattila, P. M., Rinne, J. O., Helenius, H. Y. M., & Röyttä, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051064 · Cited by 94
Degenerative Diseases of the Nervous System
Hankey, G., & Wardlaw, J. M. (2008) · CRC Press eBooks · doi:10.1201/b17272-18 · Cited by 94
Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia
Walter, U., Dressler, D. W., Wolters, A., Wittstock, M., Greim, B., & Benecke, R. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0023-9 · Cited by 93
The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
Longhena, F., Faustini, G., Missale, C., Pizzi, M., Spano, P., & Bellucci, A. (2017) · Neural Plasticity · doi:10.1155/2017/5012129 · Cited by 93
Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide
McKeith, I. G. (2007) · Practical Neurology · doi:10.1136/jnnp.2007.134163 · Cited by 92
Magnetic Resonance Imaging in Lewy Body Dementias
Watson, R., Blamire, A. M., & O'Brien, J. T. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000264614 · Cited by 91
Borroni, B., Premi, E., Formenti, A., Turrone, R., Alberici, A., Cottini, E., Rizzetti, M. C., Gasparotti, R., & Padovani, A. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.013 · Cited by 91
Development of P assive I mmunotherapies for S ynucleinopathies
Bergström, A., Kallunki, P., & Fog, K. (2015) · Movement Disorders · doi:10.1002/mds.26481 · Cited by 91
Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
Rektorová, I., Biundo, R., Mareček, R., Weis, L., Aarsland, D., & Antonini, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085595 · Cited by 90
Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease
Stav, A. L., Aarsland, D., Johansen, K. K., Hessen, E., Auning, E., & Fladby, T. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.027 · Cited by 90
Rektorová, I., Krajčovičová, L., Mareček, R., & Mikl, M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334765 · Cited by 90
Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies
Sarro, L., Senjem, M. L., Lundt, E. S., Przybelski, S. A., Lesnick, T. G., Graff-Radford, J., Boeve, B. F., Lowe, V. J., Ferman, T. J., Knopman, D. S., et al. (2016) · Brain · doi:10.1093/brain/aww193 · Cited by 89
Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies
McCleery, J., Morgan, S., Bradley, K. M., Noel-Storr, A. H., Ansorge, O., & Hyde, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010633.pub2 · Cited by 89
Ghebremedhin, E., Rosenberger, A., Rüb, U., Vukšić, M., Berhe, T., Bickeböller, H., de Vos, R. A. I., Thal, D. R., & Deller, T. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d88e63 · Cited by 89
Active immunization therapies for Parkinson's disease and multiple system atrophy
Schneeberger, A., Tierney, L., & Mandler, M. (2015) · Movement Disorders · doi:10.1002/mds.26377 · Cited by 89
Predictors of Survival in Dementia with Lewy Bodies and Parkinson Dementia
Jellinger, K. A., Wenning, G. K., & Seppi, K. (2007) · Neurodegenerative Diseases · doi:10.1159/000107703 · Cited by 88
Self-citationImpairments of speech fluency in Lewy body spectrum disorder
Ash, S., McMillan, C. T., Gross, R. G., Cook, P. A., Gunawardena, D., Morgan, B. E., Boller, A., Siderowf, A. D., & Grossman, M. (2011) · Brain and Language · doi:10.1016/j.bandl.2011.09.004 · Cited by 88
Seibert, T. M., Murphy, E. A., Kaestner, E. J., & Brewer, J. B. (2012) · Radiology · doi:10.1148/radiol.12111280 · Cited by 87
Kramberger, M. G., Auestad, B., Ptacek, S. G., Ruiz, C. A., Garre‐Olmo, J., Walker, Z., Lemstra, A. W., Londos, E., Blanc, F., Bonanni, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161109 · Cited by 86
Fonseca, L. C., Tedrus, G. M. A. S., Carvas, P. N., & Machado, E. C. F. A. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.05.001 · Cited by 85
123I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies
Orimo, S., Yogo, M., Nakamura, T., Suzuki, M., & Watanabe, H. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.001 · Cited by 85
Genetics of SynucleinopathiesPreprint
Nussbaum, R. L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024109 · Cited by 85
Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies
Cagnin, A., Gnoato, F., Jelcic, N., Favaretto, S., Zarantonello, G., Ermani, M., & Dam, M. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304095 · Cited by 84
Heron, C. J. L., Wright, S. L., Melzer, T. R., Myall, D. J., MacAskill, M. R., Livingston, L., Keenan, R. J., Watts, R., Dalrymple‐Alford, J. C., & Anderson, T. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.40 · Cited by 84
Sánchez‐Castañeda, C., Reñé, R., Ramírez‐Ruiz, B., Campdelacreu, J., Gascón, J., Falcón, C., Calopa, M., Jaumà, S., Juncadella, M., & Junqué, C. (2009) · Movement Disorders · doi:10.1002/mds.22488 · Cited by 84
Park, K. W., Kim, H. S., Cheon, S., Cha, J., Kim, S., & Kim, J. W. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.1.19 · Cited by 84
Chiba, Y., Fujishiro, H., Iseki, E., Ota, K., Kasanuki, K., Hirayasu, Y., & Satoa, K. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000339363 · Cited by 83
Jokinen, P., Scheinin, N. M., Aalto, S., Någren, K., Savisto, N., Parkkola, R. K., Rokka, J., Haaparanta‐Solin, M., Röyttä, M., & Rinne, J. O. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.021 · Cited by 83
Zhou, B., Wen, M., Yu, W., Zhang, C., & Jiao, L. (2015) · Parkinson s Disease · doi:10.1155/2015/567386 · Cited by 82
Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson?s disease
Huang, W.-S., Lee, M.-S., Lin, J.-C., Chen, C., Yang, Y.-W., Lin, S., & Wey, S. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1331-x · Cited by 82
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_12 · Cited by 81
Self-citationArguing against the proposed definition changes of PD
Boeve, B. F., Dickson, D. W., Duda, J. E., Ferman, T. J., Galasko, D. R., Galvin, J. E., Goldman, J. G., Growdon, J. H., Hurtig, H. I., Kaufer, D., et al. (2016) · Movement Disorders · doi:10.1002/mds.26721 · Cited by 81
Mollenhauer, B., Parnetti, L., Rektorová, I., Kramberger, M. G., Pikkarainen, M., Schulz‐Schaeffer, W., Aarsland, D., Svenningsson, P., Farotti, L., Verbeek, M. M., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13390 · Cited by 80
Lamberts, J. T., Hildebrandt, E. N., & Brundin, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.002 · Cited by 80
Significance of Brain Lesions in Parkinson Disease Dementia and Lewy Body Dementia
Jellinger, K. A. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000197890 · Cited by 79
Self-citationLeverenz, J. B., Watson, G. S., Shofer, J., Zabetian, C. P., Zhang, J., & Montine, T. J. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.10.003 · Cited by 78
Early α-synuclein lipoxidation in neocortex in Lewy body diseases
Dalfó, E., & Ferrer, I. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.022 · Cited by 78
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews
Shiner, T., Mirelman, A., Gana‐Weisz, M., Bar‐Shira, A., Ash, E. L., Cialic, R., Nevler, N., Gurevich, T., Bregman, N., Orr‐Urtreger, A., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1593 · Cited by 77
Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
Hansen, L. A., Daniel, S. E., Wilcock, G., & Love, S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.653 · Cited by 76
Sadiq, D., Whitfield, T. J., Lee, L., Stevens, T., Costafreda, S. G., & Walker, Z. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161089 · Cited by 76
Darweesh, S. K. L., Wolters, F. J., Postuma, R. B., Stricker, B. H. C., Albert Hofman, D., Koudstaal, P. J., Ikram, M. K., & Ikram, M. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2248 · Cited by 76
Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases
Lee, S. H., Cho, H., Choi, J. Y., Lee, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Movement Disorders · doi:10.1002/mds.27252 · Cited by 76
Parkinson’s Disease Biomarkers: Perspective from the NINDS Parkinson’s Disease Biomarkers Program
Gwinn, K. A., David, K. K., Swanson‐Fischer, C., Albin, R. L., Hillaire‐Clarke, C. S., Sieber, B.-A., Lungu, C., Bowman, F. D., Alcalay, R. N., Babcock, D., et al. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0370 · Cited by 75
Non-pharmacological interventions for Lewy body dementia: a systematic review
Connors, M. H., Quinto, L. R., McKeith, I. G., Brodaty, H., Allan, L. M., Bamford, C., Thomas, A. J., Taylor, J., & O'Brien, J. T. (2017) · Psychological Medicine · doi:10.1017/s0033291717003257 · Cited by 75
Joki, H., Higashiyama, Y., Nakae, Y., Kugimoto, C., Doi, H., Kimura, K., Kishida, H., Ueda, N., Nakano, T., Takahashi, T., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.12.018 · Cited by 75
EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study
Bonanni, L., Franciotti, R., Nobili, F. M., Kramberger, M. G., Taylor, J., Ptacek, S. G., Falasca, N. W., Famà, F., Cromarty, R. A., ONOFRJ, M. C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160435 · Cited by 74
Lee, J. E., Park, B., Song, S., Sohn, Y. H., Park, H., & Lee, P. H. (2009) · Movement Disorders · doi:10.1002/mds.22858 · Cited by 73
Kragh, C. L., Ubhi, K. K., Wyss‐Coray, T., & Masliah, E. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00545.x · Cited by 73
Dementia with Lewy bodies from the perspective of tauopathy
Iseki, E., Togo, T., Suzuki, K., Katsuse, O., Marui, W., de Silva, R., Lees, A. J., Yamamoto, T., & Kosaka, K. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0644-3 · Cited by 72
Fujishiro, H., Iseki, E., Higashi, S., Kasanuki, K., Murayama, N., Togo, T., Katsuse, O., Uchikado, H., Aoki, N., Kosaka, K., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.036 · Cited by 72
Kalaitzakis, M. E., Walls, A. J., Pearce, R. K. B., & Gentleman, S. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.005 · Cited by 72
Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity
Aarsland, D., Londos, E., & Ballard, C. G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610208008612 · Cited by 72
Synaptic proteins in CSF relate to Parkinson’s disease stage markers
Bereczki, E., Bogstedt, A., Höglund, K., Tsitsi, P., Brodin, L., Ballard, C., Svenningsson, P., & Aarsland, D. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0008-2 · Cited by 72
Galasko, D. R. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.004 · Cited by 72
Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
Friedman, J. H. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.013 · Cited by 72
Andersson, M., Zetterberg, H., Minthon, L., Blennow, K., & Londos, E. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2496 · Cited by 71
Parkinson's disease and dementia with Lewy bodies: One disease or two?
Richard, I. H., Papka, M., Rubio, A. I., & Kurlan, R. (2002) · Movement Disorders · doi:10.1002/mds.10274 · Cited by 71
Masliah, E. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3117 · Cited by 71
Rey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 71
Rapidly progressive diffuse Lewy body disease
Gaig, C., Valldeoriola, F., Gelpí, E., Ezquerra, M., Llufriú, S., Buongiorno, M., Rey, M. J., Martí, M. J., Graus, F., & TOLOSA, E. S. (2011) · Movement Disorders · doi:10.1002/mds.23506 · Cited by 70
van der Zande, J. J., Booij, J., Scheltens, P., Raijmakers, P. G. H. M., & Lemstra, A. W. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3312-x · Cited by 70
Neurodegeneration and cognition in Parkinson's disease: a review.
Ding, W., Ding, L.-J., Ff, L., Han, Y., & Mu, L. (2015) · PubMed · Cited by 70
Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature
Fagan, E., & Pihlstrøm, L. (2017) · European Journal of Neurology · doi:10.1111/ene.13258 · Cited by 70
Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 69
Early neuropsychological discriminants for Lewy body disease: an autopsy series
Yoshizawa, H., Vonsattel, J. P., & Honig, L. S. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304381 · Cited by 69
The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
Collins, L., & Williams‐Gray, C. H. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00089 · Cited by 69
The heart of PD: Lewy body diseases as neurocardiologic disorders
Goldstein, D. S., & Sharabi, Y. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.033 · Cited by 69
Dalfó, E., Albasanz, J. L., Martín, M., & Ferrer, I. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00082.x · Cited by 68
Visual object recognition and attention in Parkinson's disease patients with visual hallucinations
Meppelink, A. M., Koerts, J., Borg, M., Leenders, K. L., & van Laar, T. (2008) · Movement Disorders · doi:10.1002/mds.22270 · Cited by 68
Creese, B., Bell, E., Johar, I., Francis, P. T., Ballard, C. G., & Aarsland, D. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32549 · Cited by 68
Comprehensive treatment of dementia with Lewy bodies
Boot, B. P. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0128-z · Cited by 67
Roquet, D., Sourty, M., Botzung, A., Armspach, J., & Blanc, F. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0196-8 · Cited by 67
Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study
Watson, R., O'Brien, J. T., Barber, R., & Blamire, A. M. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211002171 · Cited by 66
Combination therapies: The next logical Step for the treatment of synucleinopathies?
Valera, E., & Masliah, E. (2015) · Movement Disorders · doi:10.1002/mds.26428 · Cited by 66
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
Lim, N., Swanson, C. R., Cherng, H. R. R., Unger, T. L., Xie, S. X., Weintraub, D. A., MAREK, K. L., Stern, M. B., Siderowf, A. D., PARS Investigators, et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.299 · Cited by 66
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies
Geiger, J. T., Ding, J., Crain, B. J., Pletniková, O., Letson, C., Dawson, T. M., Rosenthal, L. S., Pantelyat, A. Y., Gibbs, J. R., Albert, M., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.004 · Cited by 66
Peavy, G. M., Edland, S. D., Toole, B. M., Hansen, L. A., Galasko, D. R., & Mayo, A. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.07.008 · Cited by 66
Cognitive and behavioral disorders in Parkinson’s disease: an update. II: behavioral disorders
Trojano, L., & Papagno, C. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3155-7 · Cited by 66
Jellinger, K. A., & Attems, J. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000327360 · Cited by 65
Self-citationBrigo, F., Turri, G., & Tinazzi, M. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.11.004 · Cited by 64
Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies
Mukaetova-Ladinska, E. B., Andras, A., Milne, J., Abdel‐All, Z., Borr, I., Jaros, E., Perry, R. H., Honer, W. G., Cleghorn, A., Doherty, J., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827c5710 · Cited by 64
Sharp, S. I., Ballard, C. G., Ziabreva, I., Piggott, M. A., Perry, R. H., Perry, E. K., Aarsland, D., Ehrt, U., Larsen, J. O., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161058 · Cited by 63
Neurobiology of cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.131 · Cited by 63
Self-citationInvestigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies
Yamamoto, R., Iseki, E., Murayama, N., Minegishi, M., Marui, W., Togo, T., Katsuse, O., Kato, M., Iwatsubo, T., Kosaka, K., et al. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.016 · Cited by 62
Lewy body dementia and Parkinson’s disease with dementia
Dodel, R. C., Csóti, I., Ebersbach, G., Fuchs, G., Hahne, M., Kuhn, W., Oechsner, M., Jost, W. H., Reichmann, H., & Schulz, J. B. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5007-0 · Cited by 62
Cognitive Impairment in Parkinson’s Disease and Dementia with Lewy Bodies: A Spectrum of Disease
Gross, R. G., Siderowf, A. D., & Hurtig, H. I. (2007) · Neurosignals · doi:10.1159/000109756 · Cited by 62
Sarro, L., Tosakulwong, N., Schwarz, C. G., Graff‐Radford, J., Przybelski, S. A., Lesnick, T. G., Zuk, S. M., Reid, R. I., Raman, M. R., Boeve, B. F., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.07.003 · Cited by 62
Duration and Pathologic Correlates of Lewy Body Disease
Graff‐Radford, J., Aakre, J. A., Savica, R., Boeve, B. F., Kremers, W. K., Ferman, T. J., Jones, D. T., Kantarci, K., Knopman, D. S., Dickson, D. W., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4926 · Cited by 62
Garcia‐Esparcia, P., López‐González, I., Grau‐Rivera, O., Garrido, M. G., Koneti, A., Llorens, F., Zafar, S., Carmona, M., del Río, J. A., Zerr, I., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00089 · Cited by 62
MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
Colom‐Cadena, M., Gelpí, E., Martí, M. J., Charif, S., Dols‐Icardo, O., Blesa, R., Clarimón, J., & Lleó, A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.015 · Cited by 61
Stubendorff, K., Larsson, V., Ballard, C. G., Minthon, L., Aarsland, D., & Londos, E. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005158 · Cited by 61
Iizuka, T., & Kameyama, M. (2016) · Annals of Nuclear Medicine · doi:10.1007/s12149-016-1076-9 · Cited by 61
Neuroanatomical changes in Parkinson′s disease in relation to cognition: An update
Prakash, K., Bannur, B. M., Chavan, M., Saniya, K., Sailesh, K. S., & Archana, R. (2016) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/2231-4040.191416 · Cited by 61
Cortical Lewy body disease and Parkinson's disease dementia
Burn, D. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247607.34697.a2 · Cited by 60
α-synuclein induced synapse damage is enhanced by amyloid-β1-42
Bate, C., Gentleman, S., & Williams, A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-55 · Cited by 59
Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease.
Hely, M. A., Reid, W., Halliday, G. M., McRitchie, D. A., Leicester, J., Joffe, R., Brooks, W. S., Broe, G. A., & Morris, J. G. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.5.531 · Cited by 59
Neuropathologic Findings of Dementia with Lewy Bodies (DLB) in a Population-based Vantaa 85+ Study
Oinas, M., Polvikoski, T. M., Sulkava, R. O., Myllykangas, L., Juva, K., Notkola, I.-L. K., Rastas, S., Niinistö, L., Kalimo, H., & Paetau, A. E. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1169 · Cited by 58
Vranová, H. P., Hényková, E., Kaiserová, M., Menšíková, K., Vaštík, M., Mareš, J., Hluštík, P., Zapletalová, J., Strnad, M., Stejskal, D., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.05.052 · Cited by 57
An evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology
Wider, C. W., Ross, O. A., Nishioka, K., Heckman, M. G., Vilariño‐Güell, C., Jasińska‐Myga, B., Erketin-Taner, N., Rademakers, R., Graff‐Radford, N. R., Mash, D. C., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301413 · Cited by 57
Peraza, L. R., Colloby, S. J., Firbank, M., Greasy, G. S., McKeith, I. G., Kaiser, M., O'Brien, J. T., & Taylor, J. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4342 · Cited by 56
Skogseth, R. E., Brønnick, K., Pereira, J. B., Mollenhauer, B., Weintraub, D. A., Fladby, T., & Aarsland, D. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150682 · Cited by 56
The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies
Elder, G. J., Mactier, K. E., Colloby, S. J., Watson, R., Blamire, A. M., O'Brien, J. T., & Taylor, J. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4719 · Cited by 56
Hepp, D. H., Ruiter, A. M., Galis, Y., Voorn, P., Rozemüller, A. J. M., Berendse, H. W., Foncke, E. M. J., & van de Berg, W. D. J. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000014 · Cited by 55
Tiraboschi, P., Corso, A., Guerra, U. P., Nobili, F. M., Piccardo, A., Calcagni, M. L., Volterrani, D., Cecchin, D., Tettamanti, M., Antelmi, L., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24717 · Cited by 55
Uchihara, T. (2016) · Neuropathology · doi:10.1111/neup.12348 · Cited by 55
Miki, Y., Tanji, K., Mori, F., Utsumi, J., Sasaki, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2015) · Brain Pathology · doi:10.1111/bpa.12297 · Cited by 54
Kalaitzakis, M. E., Pearce, R. K. B., & Gentleman, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.083 · Cited by 54
PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies
Gomperts, S. N., Marquié, M., Locascio, J. J., Bayer, S., Johnson, K. A., & Growdon, J. H. (2015) · Neurodegenerative Diseases · doi:10.1159/000441421 · Cited by 54
Global Expression Profiling in Epileptogenesis: Does It Add to the Confusion?
Wang, Y. Y., Smith, P., Murphy, M. A., & Cook, M. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00254.x · Cited by 53
Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load
Tiraboschi, P., Attems, J., Thomas, A. J., Brown, A. J., Jaros, E., Lett, D. J., Ossola, M., Perry, R. H., Ramsay, L., Walker, L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001204 · Cited by 53
Cholinergic and perfusion brain networks in Parkinson disease dementia
Colloby, S. J., McKeith, I. G., Burn, D. J., Wyper, D. J., O'Brien, J. T., & Taylor, J. (2016) · Neurology · doi:10.1212/wnl.0000000000002839 · Cited by 53
Santpere, G., Garcia‐Esparcia, P., Andrés‐Benito, P., Lorente-Galdós, B., Navarro, A., & Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12511 · Cited by 53
Symptoms associated with Lewy body disease in mild cognitive impairment
Donaghy, P. C., Barnett, N. A., Olsen, K., Taylor, J., McKeith, I. G., O'Brien, J. T., & Thomas, A. J. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4742 · Cited by 53
APOE, thought disorder, and SPARE‐AD predict cognitive decline in established Parkinson's disease
Tropea, T. F., Xie, S. X., Rick, J. H., Chahine, L. M., Dahodwala, N. A., Doshi, J. J., Davatzikos, C. A., Shaw, L. M. J., Deerlin, V. M. V., Trojanowski, J. Q., et al. (2017) · Movement Disorders · doi:10.1002/mds.27204 · Cited by 53
Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan
Yu, R., Wu, R., Tai, C., Lin, C., Cheng, T.-W., & Hua, M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.06.002 · Cited by 52
Nie, K., Zhang, Y., Gan, R., Wang, L., Zhao, J., Huang, Z., Tang, H., & Wang, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.024 · Cited by 52
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies
Labbé, C., Heckman, M. G., Lorenzo‐Betancor, O., Soto‐Ortolaza, A. I., Walton, R. L., Murray, M. E., Allen, M., Uitti, R. J., Wszołek, Z. K., Smith, G. E., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.05.002 · Cited by 52
Neural correlates of visual hallucinations in dementia with Lewy bodies
Heitz, C., Noblet, V., Cretin, B., Philippi, N., Kremer, L. D., Stackfleth, M., Hubelé, F., Armspach, J. P., Namer, I. J., & Blanc, F. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0091-0 · Cited by 51
Blanc, F., Mahmoudi, R., Jonveaux, T., Galmiche, J., Chopard, G., Cretin, B., Demuynck, C., Martin‐Hunyadi, C., Philippi, N., Sellal, F., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0272-8 · Cited by 51
Somme, J. H., Gómez‐Esteban, J. C., Molano, A., Tijero, B., Lezcano, E., & Zarranz, J. J. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.047 · Cited by 50
Morimoto, S., Takao, M., Hatsuta, H., Nishina, Y., Komiya, T., Sengoku, R., Nakano, Y., Uchino, A., Sumikura, H., Saito, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171524 · Cited by 50
Cersosimo, M. G. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2733-6 · Cited by 50
Elder, G. J., Firbank, M., Kumar, H., Chatterjee, P., Chakraborty, T., Dutt, A., & Taylor, J. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001180 · Cited by 49
Can we clinically diagnose dementia with Lewy bodies yet?
Huang, Y. M., & Halliday, G. M. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-4 · Cited by 49
Parkinson's disease dementia can be easily detected in routine clinical practice
Dujardin, K., Dubois, B., Tison, F., Durif, F., Bourdeix, I., Péré, J.-J., Duhamel, A., & for the EXECUTIVE study group (2010) · Movement Disorders · doi:10.1002/mds.23391 · Cited by 49
An update on the genetics of dementia with Lewy bodies
Vergouw, L. J. M., van Steenoven, I., van de Berg, W. D. J., Teunissen, C. E., Swieten, J. C. V., Bonifati, V., Lemstra, A. W., & de Jong, F. J. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.009 · Cited by 49
Weil, R. S., Lashley, T., Brás, J., Schrag, A. E., & Schott, J. M. (2017) · F1000Research · doi:10.12688/f1000research.11725.1 · Cited by 49
Varanese, S., Perfetti, B., Monaco, D., Thomas, A., Bonanni, L., Tiraboschi, P., & ONOFRJ, M. C. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5453-3 · Cited by 48
Winslow, A. R., Moussaud, S., Zhu, L., Post, K. L., Dickson, D. W., Berezovska, O., & McLean, P. J. (2014) · Brain · doi:10.1093/brain/awu119 · Cited by 48 · cited 1×
“1 3 PSEN1 proteins was significantly increased in post-mortem brain tissues from cases with DLB and familial AD associated with known PSEN1 mutations that may explain the overlap between synucleinopathies and some forms of AD (Winslow et al. 2014).”
BackgroundImaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies
Gomperts, S. N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0472-6 · Cited by 47
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies
Rohan, Z., Milenković, I., Lutz, M. I., Matěj, R., & Kovács, G. G. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw087 · Cited by 47
Mild cognitive impairment in Parkinson disease: heterogenous mechanisms
Jellinger, K. A. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0771-5 · Cited by 46
Self-citationFirbank, M., Burn, D. J., McKeith, I. G., & O'Brien, J. T. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1359 · Cited by 46
LRRK2 variation and dementia with Lewy bodies
Heckman, M. G., Soto‐Ortolaza, A. I., Sánchez-Contreras, M., Murray, M. E., Pedraza, O., Diehl, N. N., Walton, R. L., Labbé, C., Lorenzo‐Betancor, O., Uitti, R. J., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.07.015 · Cited by 46
The New Diagnostic Criteria for Parkinson's Disease.
Postuma, R., & Berg, D. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.01.008 · Cited by 46
Villemagne, V. L., Okamura, N., Pejoska, S., Drago, J., Mulligan, R. S., Chételat, G., Ackermann, U., O'Keefe, G., Jones, G., Gong, S., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.142 · Cited by 45
Gene expression profiling of brain samples from patients with Lewy body dementia
Pietrzak, M., Papp, A. C., Curtis, A., Handelman, S. K., Kataki, M., Scharre, D. W., Rempała, G. A., & Sadée, W. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.114 · Cited by 45
Cited by
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Jellinger, K. A., & Korczyn, A. D. (2018) · BMC Medicine · doi:10.1186/s12916-018-1016-8 · Cited by 385
Self-citationNew evidence on the management of Lewy body dementia
Taylor, J.-P., McKeith, I. G., Burn, D. J., Boeve, B. F., Weintraub, D., Bamford, C., Allan, L. M., Thomas, A. J., & O'Brien, J. T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30153-x · Cited by 347
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Gasca-Salas, C., Fernández-Rodríguez, B., Pineda-Pardo, J. A., Rodríguez-Rojas, R., Obeso, I., Hernández-Fernández, F., del Álamo, M., Mata, D., Guida, P., Ordás-Bandera, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21022-9 · Cited by 319
Metadata
- Authors
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2017-12-08
- Volume
- 125
- Issue
- 4
- Pages
- 615-650
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2773780551
- Cited by
- 264
- References
- 499
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.